XML 45 R121.htm IDEA: XBRL DOCUMENT v3.20.1
Note 27 - Share-based Expenses (Details Textual)
 1 Months Ended 12 Months Ended
Jan. 19, 2020
May 30, 2018
Feb. 27, 2018
Jun. 26, 2017
Jun. 23, 2017
USD ($)
Feb. 20, 2012
Jul. 31, 2017
GBP (£)
Dec. 31, 2019
USD ($)
Dec. 31, 2018
USD ($)
Dec. 31, 2017
USD ($)
Jun. 22, 2017
Statement Line Items [Line Items]                      
Liabilities from share-based payment transactions               $ 540,000 $ 2,090,000 [1]    
Expense from cash-settled share-based payment transactions               107,000 43,000 $ 311,000  
Expense from cash-settled share-based payment transactions in which goods or services received did not qualify for recognition as assets               $ 689,000 $ 315,000 [2] 976,000 [2]  
Option life, share options granted   3 3                
Share-based compensation arrangement, percentage of outstanding stock maximum               10.00%      
Weighted average remaining contractual life of outstanding share options               2 years 51 days 3 years 51 days    
Expense from equity-settled share-based payment transactions in which goods or services received did not qualify for recognition as assets         $ 806,000     $ 14,000 [2] 835,000 [2]  
Share consolidation ratio       5              
Borrowings, adjustment to interest rate basis                     10.00%
Borrowings, interest rate         7.25%            
Dividend loans, Percentage of dividend as payment of interest         80.00% 80.00%          
Faciliation and advanced dividend loans [member]                      
Statement Line Items [Line Items]                      
Expense from equity-settled share-based payment transactions in which goods or services received did not qualify for recognition as assets         $ 806,000            
Borrowings, interest rate         7.25%            
Dividend loans, Percentage of dividend as payment of interest         80.00%            
LIBOR [member] | Faciliation and advanced dividend loans [member]                      
Statement Line Items [Line Items]                      
Borrowings, adjustment to interest rate basis                     10.00%
Mr. J Staiger [member]                      
Statement Line Items [Line Items]                      
Expense from equity-settled share-based payment transactions in which goods or services received did not qualify for recognition as assets               $ 0 14,000 $ 29,000  
Restricted stock units (RSUs) [member]                      
Statement Line Items [Line Items]                      
Vesting period of other equity instruments               3      
Weighted average fair value at measurement date, other equity instruments granted               $ 8.46 $ 5.46    
Restricted stock units (RSUs) [member] | Potential ordinary share transactions [member]                      
Statement Line Items [Line Items]                      
Number of other equity instruments granted in share-based payment arrangement 17,585                    
Performance share units (PSUs) [member]                      
Statement Line Items [Line Items]                      
Vesting period of other equity instruments               3      
Performance probability                 85.00% 94.00%  
Liabilities from share-based payment transactions               $ 524,000 $ 2,043,000    
Expense from cash-settled share-based payment transactions               107,000 43,000 $ 311,000  
Weighted average fair value at measurement date, other equity instruments granted               $ 8.19 5.46    
Performance share units (PSUs) [member] | Potential ordinary share transactions [member]                      
Statement Line Items [Line Items]                      
Number of other equity instruments granted in share-based payment arrangement 121,332                    
Performance share units (PSUs) [member] | Bottom of range [member]                      
Statement Line Items [Line Items]                      
Performance probability               93.00%      
Performance share units (PSUs) [member] | Top of range [member]                      
Statement Line Items [Line Items]                      
Performance probability               100.00%      
PSUs and RSUs [member]                      
Statement Line Items [Line Items]                      
Value of other equity instruments exercised or vested in share-based payment arrangement               $ 2,243,000      
Value of other equity instruments exercised or vested in share-based payment arrangement, share capital               963,000      
Cash-settled awards [member]                      
Statement Line Items [Line Items]                      
Vesting period of other equity instruments             3        
Liabilities from share-based payment transactions               16,000 47,000    
Number of other equity instruments granted in share-based payment arrangement             52,282        
Weighted average fair value at measurement date, other equity instruments granted | £             £ 6.07        
Expense from cash-settled share-based payment transactions in which goods or services received did not qualify for recognition as assets               $ 73,000 $ 97,000 $ 123,000  
Omnibus Equity Incetive Compensation Plan [member]                      
Statement Line Items [Line Items]                      
Option life, share options granted               10      
Rolling Stock Option Plan [member]                      
Statement Line Items [Line Items]                      
Option life, share options granted               5      
[1] The Group initially applied IFRS 16 on January 1, 2019, using the modified retrospective approach. Under this approach, comparative information is not restated. There was no cumulative effect of initially applying IFRS 16 to recognise in retained earnings at the date of initial application.
[2] The Group initially applied IFRS 16 on January 1, 2019, using the modified retrospective approach. Under this approach, comparative information is not restated. There was no cumulative effect of initially applying IFRS 16 to recognise in retained earnings at the date of initial application.